adults conducted in spring 2026, finds that about 18% of American adults are using a GLP-1 medication, up from approximately 14% in 2025
Patients should be monitored for signs of dehydration, especially during dose titration, and should maintain adequate fluid intake unless otherwise directed by their healthcare provider
Whilst retatrutide is not currently available in the UK outside of clinical trials, your GP can help you understand which licensed treatments may be appropriate for your individual circumstances, taking into account your medical history, current medications, and weight management goals
Activated mast cells release pro-inflammatory cytokines such as IL-1, IL-6 and TNF- as well as bronchoconstrictor mediators such as histamine, prostaglandin-D2 and leukotriene-C4
Strains involve muscles and tendons